Literature DB >> 32234310

The Function of Tafazzin, a Mitochondrial Phospholipid-Lysophospholipid Acyltransferase.

Michael Schlame1, Yang Xu2.   

Abstract

Tafazzin is a mitochondrial enzyme that exchanges fatty acids between phospholipids by phospholipid-lysophospholipid transacylation. The reaction alters the molecular species composition and, as a result, the physical properties of lipids. In vivo, the most important substrate of tafazzin is the mitochondria-specific lipid cardiolipin. Tafazzin mutations cause the human disease Barth syndrome, which presents with cardiomyopathy, skeletal muscle weakness, fatigue, and other symptoms, probably all related to mitochondrial dysfunction. The reason why mitochondria require tafazzin is still not known, but recent evidence suggests that tafazzin may lower the energy cost associated with protein crowding in the inner mitochondrial membrane.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Barth syndrome; cardiolipin; membrane lipids; mitochondria

Mesh:

Substances:

Year:  2020        PMID: 32234310      PMCID: PMC7483898          DOI: 10.1016/j.jmb.2020.03.026

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  51 in total

1.  Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.

Authors:  Zhiming Gu; Fredoen Valianpour; Shuliang Chen; Frederic M Vaz; Gertjan A Hakkaart; Ronald J A Wanders; Miriam L Greenberg
Journal:  Mol Microbiol       Date:  2004-01       Impact factor: 3.501

Review 2.  A note on the kinetics of enzyme action: a decomposition that highlights thermodynamic effects.

Authors:  Elad Noor; Avi Flamholz; Wolfram Liebermeister; Arren Bar-Even; Ron Milo
Journal:  FEBS Lett       Date:  2013-07-23       Impact factor: 4.124

Review 3.  The molecular biology of the group VIA Ca2+-independent phospholipase A2.

Authors:  Z Ma; J Turk
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

4.  The Taz1p transacylase is imported and sorted into the outer mitochondrial membrane via a membrane anchor domain.

Authors:  Jenny D Herndon; Steven M Claypool; Carla M Koehler
Journal:  Eukaryot Cell       Date:  2013-09-27

5.  Tafazzins from Drosophila and mammalian cells assemble in large protein complexes with a short half-life.

Authors:  Yang Xu; Ashim Malhotra; Steven M Claypool; Mindong Ren; Michael Schlame
Journal:  Mitochondrion       Date:  2015-01-15       Impact factor: 4.160

6.  Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.

Authors:  Tomohiro Kimura; Atsuko K Kimura; Mindong Ren; Bob Berno; Yang Xu; Michael Schlame; Richard M Epand
Journal:  Biochemistry       Date:  2018-03-30       Impact factor: 3.162

7.  Bloodspot assay using HPLC-tandem mass spectrometry for detection of Barth syndrome.

Authors:  Willem Kulik; Henk van Lenthe; Femke S Stet; Riekelt H Houtkooper; Helena Kemp; Janet E Stone; Colin G Steward; Ronald J Wanders; Frédéric M Vaz
Journal:  Clin Chem       Date:  2007-12-10       Impact factor: 8.327

8.  The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome.

Authors:  Steven M Claypool; Pinmanee Boontheung; J Michael McCaffery; Joseph A Loo; Carla M Koehler
Journal:  Mol Biol Cell       Date:  2008-09-17       Impact factor: 4.138

9.  Mitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzins.

Authors:  Steven M Claypool; J Michael McCaffery; Carla M Koehler
Journal:  J Cell Biol       Date:  2006-07-31       Impact factor: 10.539

10.  Structural and functional analyses of Barth syndrome-causing mutations and alternative splicing in the tafazzin acyltransferase domain.

Authors:  Atsushi Hijikata; Kei Yura; Osamu Ohara; Mitiko Go
Journal:  Meta Gene       Date:  2015-04-22
View more
  7 in total

1.  Clinical variant interpretation and biologically relevant reference transcripts.

Authors:  Fernando Pozo; José Manuel Rodriguez; Jesús Vázquez; Michael L Tress
Journal:  NPJ Genom Med       Date:  2022-10-18       Impact factor: 6.083

2.  Current Knowledge on the Role of Cardiolipin Remodeling in the Context of Lipid Oxidation and Barth Syndrome.

Authors:  Zhuqing Liang; Michael W Schmidtke; Miriam L Greenberg
Journal:  Front Mol Biosci       Date:  2022-05-27

Review 3.  Monolysocardiolipin (MLCL) interactions with mitochondrial membrane proteins.

Authors:  Anna L Duncan
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

Review 4.  Role of Tafazzin in Mitochondrial Function, Development and Disease.

Authors:  Michael T Chin; Simon J Conway
Journal:  J Dev Biol       Date:  2020-05-23

5.  Depletion of cardiac cardiolipin synthase alters systolic and diastolic function.

Authors:  Elia Smeir; Sarah Leberer; Annelie Blumrich; Georg Vogler; Anastasia Vasiliades; Sandra Dresen; Carsten Jaeger; Yoann Gloaguen; Christian Klose; Dieter Beule; P Christian Schulze; Rolf Bodmer; Anna Foryst-Ludwig; Ulrich Kintscher
Journal:  iScience       Date:  2021-10-19

Review 6.  Studying Lipid-Related Pathophysiology Using the Yeast Model.

Authors:  Tyler Ralph-Epps; Chisom J Onu; Linh Vo; Michael W Schmidtke; Anh Le; Miriam L Greenberg
Journal:  Front Physiol       Date:  2021-10-28       Impact factor: 4.566

7.  Dietary lysophosphatidylcholine regulates diacylglycerol, cardiolipin and free fatty acid contents in the fillet of turbot.

Authors:  Houguo Xu; Xing Luo; Yuliang Wei; Mengqing Liang
Journal:  Food Chem X       Date:  2022-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.